🔬 IGF-1 LR3 – Research Peptide (1mg)
IGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg3) is a modified analog of IGF-1 studied in controlled laboratory settings for its interaction with cellular signaling pathways, receptor-binding dynamics, and protein synthesis mechanisms. Researchers utilize this peptide in experimental models investigating cell proliferation, differentiation pathways, and intracellular signaling cascades under tightly controlled research conditions.
Lyophilized powder supplied in standard laboratory vials.
Not for injection. Not for clinical, therapeutic, or diagnostic use.
🔹 Product Specifications
- Form: Lyophilized Powder
- Amount: 1mg per vial
- Purity: ≥ 98%
- Appearance: White to off-white powder
- Storage: Store in a cool, dry environment. Refrigerate after reconstitution.
🧪 Molecular Information
- Molecular Formula: C400H625N111O115S7
- Molecular Weight: ~9111.0 g/mol
- Structure: Recombinant analog of IGF-1 with Arg substitution at position 3 and extended peptide chain
🔬 Research Applications
- Cellular proliferation and differentiation pathway research
- IGF receptor-binding and signaling pathway studies
- Protein synthesis and intracellular signaling cascade modeling
- Long-acting IGF analog behavior in controlled laboratory environments
💡 Interested in the Science?
Explore how modified IGF analogs like IGF-1 LR3 are evaluated in laboratory research involving receptor-binding dynamics, intracellular signaling pathways, and peptide-mediated cellular response models.
🔬 IGF-1 LR3 – Frequently Asked Questions (Research Use Only)
The following FAQs are intended for qualified researchers and laboratory professionals seeking scientific information about IGF-1 LR3 peptide. All content is provided for informational purposes only and does not constitute medical, clinical, or therapeutic advice.
Q: What is IGF-1 LR3 peptide?
IGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg3) is a recombinant analog of IGF-1 featuring an arginine substitution at position 3 and an extended amino acid sequence. It is investigated in laboratory research involving receptor-binding dynamics, intracellular signaling pathways, and peptide-mediated cellular response models. Supplied as a research-use-only lyophilized powder, IGF-1 LR3 is not intended for clinical, therapeutic, or diagnostic use.
Q: What are the primary research applications of IGF-1 LR3?
In controlled laboratory environments, IGF-1 LR3 is utilized in studies involving IGF receptor-binding interactions, cellular proliferation modeling, intracellular signaling cascades, and peptide stability analysis. It is supplied exclusively as a research-use-only material and is not intended for clinical, therapeutic, or diagnostic applications.
Q: How should IGF-1 LR3 lyophilized powder be stored in a laboratory setting?
IGF-1 LR3 should be stored in a cool, dry environment away from moisture, light, and temperature fluctuations. Lyophilized powder maintains stability under refrigerated conditions (2–8°C). Once reconstituted, the solution should be refrigerated and used within appropriate laboratory timeframes. Repeated freeze-thaw cycles should be avoided to maintain compound integrity.
Q: Is IGF-1 LR3 approved for human use or clinical applications?
No. IGF-1 LR3 is classified strictly as a research-use-only (RUO) laboratory material. It has not been approved by any regulatory authority, including the FDA, for human therapeutic, diagnostic, or clinical use. It is intended solely for controlled in vitro or preclinical laboratory research conducted by qualified scientific personnel.
Q: What analytical methods verify IGF-1 LR3 peptide purity?
Research-grade IGF-1 LR3 purity is verified using High-Performance Liquid Chromatography (HPLC) and confirmed via mass spectrometry (MS) to validate molecular weight and structural integrity. These analytical methods ensure the compound meets ≥98% purity standards required for consistent laboratory research. A Certificate of Analysis (CoA) is provided to support batch verification.
